Shaperon
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 2 Trial of HY209gel in Atopic Dermatitis Patients (NCT06024499) | Shaperon | 2024-03-01 |
| Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia Patients (NCT05352347) | Shaperon | 2022-04-12 |
| Clinical Trial to Investigate the Efficacy and Safety of NuSepin® in COVID-19 Pneumonia Patients (NCT04565379) | Shaperon | 2020-09-24 |
| A Phase II Study of HY209 Gel for Atopic Dermatitis Patients (Shaperon) (NCT04530643) | Shaperon | 2020-08-26 |
| A Study of HY209 in Healthy Male Volunteers for Sepsis (NCT04255979) | Shaperon | 2019-12-05 |
| A Phase I Study of HY209 Gel in Healthy Male Volunteers for Atopic Dermatitis (NCT03492398) | Shaperon | 2018-01-29 |
Track Shaperon automatically
Every clearance here is in the API, with alerts when new ones post.